Radionuclide perfusion imaging remains the dominant force in coronary artery disease assessment, with SPECT leading the charge and PET on a steady rise. In this episode of JNC CardioConnect, Journal of Nuclear Cardiology (JNC) Editor-in-Chief Marcelo F. Di Carli, MD, MASNC, speaks with physicians at Houston Methodist Hospital to discuss their recent article (https://www.journalofnuclearcardiology.org/article/S1071-3581(24)00712-8/fulltext) and break down the latest Medicare data, highlighting usage trends in cardiac imaging, underutilized opportunities with PET/CT and myocardial blood flow, and what it all means for the future of cardiac imaging.
- Category
- Cardiology

Be the first to comment